News
- Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Therapeutics, Inc.
01/19/2021 / 22:01 - GlobeNewswire
-
- Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer
01/19/2021 / 22:00 - GlobeNewswire
-
- Thingsfactory introduces new technology for fever and behaviour detection in Livestock
01/19/2021 / 21:15 - GlobeNewswire
-
- CAI PUBLISHES NEW RESOURCE TO SUPPORT RESIDENTS LIVING IN CONDOMINIUMS AND HOMEOWNERS ASSOCIATIONS
01/19/2021 / 20:57 - GlobeNewswire
-
- CD PROJEKT DEADLINE ALERT: Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In CD Projekt To Contact Him Directly To Discuss Their Options
01/19/2021 / 20:44 - GlobeNewswire
-
- QIWI DEADLINE ALERT: Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Qiwi To Contact Him Directly To Discuss Their Options
01/19/2021 / 20:27 - GlobeNewswire
-
- ORTHOPEDIATRICS CORPORATION INVESTOR ALERT: Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In OrthoPediatrics Corporation To Contact Him Directly To Discuss Their Options
01/19/2021 / 20:19 - GlobeNewswire
-
- Curves Introduces Virtual Group Coaching Option for MyCurves On Demand
01/19/2021 / 19:59 - GlobeNewswire
-
- BodyGuardz Announces Eco PRTX, the First Eco-Friendly, Shatterproof Screen Protector
01/19/2021 / 19:45 - GlobeNewswire
-
- Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Restaurant Brands International Inc. Investors
01/19/2021 / 19:18 - GlobeNewswire
Real-time